Request Demo
Last update 18 Jan 2025
Recombinant protein COVID-19 vaccine (trivalent) (WestVac Biopharma)
Last update 18 Jan 2025
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine, Genetically engineered subunit vaccine |
Synonyms Recombinant COVID19 vaccine (Sf9 cells) (trivalent), WSK-V102D |
Target |
Mechanism SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with Recombinant protein COVID-19 vaccine (trivalent) (WestVac Biopharma)NCT05911061
A Multicenter, Randomized, Double-Blind, Controlled, Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination to Evaluate Efficacy, Safety and Immunogenicity in Population Aged 18 Years Old and Above
ChiCTR2300068248
Clinical study on the safety, immunogenicity and protective efficacy of the booster vaccination of WSK-V102 series, WSK-V106 series recombinant COVID-19 vaccine in people aged 18 years old and above who have completed 2 or 3 does COVID-19 vaccines
ChiCTR2300073044
A Phase ? Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination to Evaluate Efficacy, Safety and Immunogenicity
100 Clinical Results associated with Recombinant protein COVID-19 vaccine (trivalent) (WestVac Biopharma)
Login to view more data
100 Translational Medicine associated with Recombinant protein COVID-19 vaccine (trivalent) (WestVac Biopharma)
Login to view more data
100 Patents (Medical) associated with Recombinant protein COVID-19 vaccine (trivalent) (WestVac Biopharma)
Login to view more data
100 Deals associated with Recombinant protein COVID-19 vaccine (trivalent) (WestVac Biopharma)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| COVID-19 | Phase 3 | - | 30 Dec 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free